Share Price:

APNASPENAspen Pharmacare Hldgs12201173 (1.44%)
Our Response to Covid
Country Sites

Aspen will be in a closed period from 1 January 2025 until the publication of the Interim Results on the JSE SENS platform on 3 March 2025.

Day: March 3, 2025

H1 2025 Interim Results Booklet

View or Download

H1 2025 Interim Results Presentation

View or Download

Stakeholder Update Call Webcast – 23 April 2025

Watch the Webcast

Aspen delivers strong results and advances its strategic ambitions

Stephen Saad Aspen Group Chief Executiv

Aspen Pharmacare Holdings has reported positive Group interim financial results for the six months ended 31 December 2024.

Stakeholder Notes – 23 April 2025

View or Download

Our Purpose

Find out more
To improve the health and quality of life of patients.

Our Vision

Find out more
To deliver value to all our stakeholders as a responsible corporate citizen that provides high-quality, affordable medicines globally.

Our Values

Find out more
Define the foundation on which Aspen has been built. These are the values we share as we work together toward achieving the vision of the Group.
aspen-holdings-logo-white-img

Aspen Holdings
www.aspenpharma.com
Hotline (South Africa)
0800 122 912

Medical Careline (South Africa) 0800 118 088

Facebook-f Twitter-square Instagram Linkedin

About Aspen

We Care

Careers

Contact Us

ASPEN PHARMACARE HOLDINGS LTD:
Switchboard: +27 31 580-8600

Aspen Place
9 Rydall Vale Park
Douglas Saunders Drive
La Lucia Ridge
South Africa

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.